Alliance Global Partners Maintains Buy on Icecure Medical, Lowers Price Target to $4
Portfolio Pulse from Benzinga Newsdesk
Alliance Global Partners analyst Ben Haynor maintains a 'Buy' rating on Icecure Medical (NASDAQ:ICCM) but lowers the price target from $4.25 to $4.
August 15, 2023 | 1:17 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Icecure Medical's price target has been lowered from $4.25 to $4 by Alliance Global Partners, though the 'Buy' rating is maintained.
The news directly pertains to Icecure Medical (ICCM). The lowering of the price target might indicate a slightly less optimistic outlook for the company's stock, but the maintained 'Buy' rating suggests that the analyst still sees potential for growth. This could lead to mixed reactions in the market, hence the neutral score.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100